ADME, DMPK, and Bioanalytical Support — Aurigene

For us, ADME, DMPK, and bioanalytical support is most valuable when every activity is tied to a clear program question. We begin by understanding the development stage, available inputs, known risks, and the audience for the final deliverables. From there, we define a scope that is scientifically grounded, operationally realistic, and designed to produce information your team can act on.

Our ADME, DMPK, and bioanalytical support capabilities

We generate and interpret ADME, DMPK, and bioanalytical data to guide compound design, candidate selection, and nonclinical studies. The plan can integrate in vitro disposition assays, exposure assessment, metabolite work, method development, sample analysis, and PK interpretation. Results are reviewed against program criteria so liabilities, uncertainties, and next experiments are visible to the project team. Designed for discovery and preclinical programs that need analysis tied to molecule progression rather than stand-alone sample processing. This work sits within our Bioanalytical Services capabilities and is coordinated with the wider program context when the scope requires it.

• A scope for ADME, DMPK, and bioanalytical support tied to the program objective
• Defined inputs, responsibilities, review points, and decision criteria
• Deliverables organized for scientific and operational follow-through

How we shape the scope

During scoping, we work through the objective, acceptance criteria, dependencies, and potential decision points in plain language. We also identify assumptions that need to be tested before they become schedule or budget problems. The resulting plan defines responsibilities on both sides, shows where reviews will occur, and makes clear how changes in inputs or findings will be handled. This creates a shared operating picture without locking the project into details that should remain flexible.

Working with Aurigene

Our team treats communication as part of the technical service. We establish contacts, review points, and escalation paths at the outset, then use them to keep decisions moving. Interim conversations distinguish confirmed findings from working interpretations and unresolved questions. That separation is important: it lets the program team act with appropriate confidence while giving specialists space to investigate observations that require more context.

Deliverables built for the next decision

Outputs are planned for the people who will use them next. At kickoff, we agree on the required files, summaries, documentation, and review process rather than assuming a standard package will fit every program. Our final review connects the deliverables back to the original objective and highlights material observations, limitations within the performed scope, and follow-up questions. This makes the handoff more useful for internal review, partner discussions, and subsequent development planning.

Before execution, we also confirm how the work will connect with adjacent activities and which handoffs could affect quality, timing, or interpretation. That check helps us identify missing inputs early, avoid duplicated effort, and keep the completed package consistent with the program's immediate priorities. We record the decisions made during this alignment so the project team has a stable reference as work progresses.

Planning your ADME, DMPK, and bioanalytical support project with Aurigene

To plan a ADME, DMPK, and bioanalytical support project, share the program stage, primary objective, available inputs, known constraints, desired timing, and the decision the work needs to support. We will use that information to frame a focused technical discussion and return a scope that identifies the proposed approach, responsibilities, assumptions, review points, deliverables, and major cost or schedule drivers.